Skip to content
Insider tapeLive · 5:07 PM ET
My stocks

Daniel J. Lippis

At a glance: Daniel J. Lippis is Cvp, Tavr at Edwards Lifesciences (EW). Their latest SEC Form 4, filed Nov 10, 2026, reported a sale of $65K. On file: 0 purchase lines ($0) and 15 sale lines ($989K).

Disclosed holdings: about $4.2M of EW stock: 40,034 shares reported on their latest Form 4 (filed Nov 10, 2026), valued at the Nov 19, 2026 close of $103.72. This counts only EW shares reported to the SEC; it leaves out cash, other investments, options and unvested awards, so it is not total net worth.

Cvp, Japac at Edwards Lifesciences Corp (EW); Cvp, Tavr at Edwards Lifesciences Corp (EW)

Purchase track record

Not enough history. Based on 0 purchases with a full 90 days of price history.

—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $989K

Daniel J. Lippis's InsiderPrint

15 trades from SEC Form 4 filings, 2025 to 2026, drawn as one fingerprint.

InsiderPrint of Daniel J. Lippis: 15 trades, 2025 to 20262025: 0 buys, 2 sales2026: 0 buys, 13 sales

Reading this print: Almost only sells, trading about 15 times a year, typically $65K a trade; most sales are on a pre-planned 10b5-1 schedule.

  • Bump outward: a purchase (0)
  • Dent inward: a sale (15)
  • One ring per year, oldest in the middle, Jan at the top going clockwise. Bigger bumps mean more dollars.

Insiders with a similar print

  1. Lisa BodensteinerSee Remarks · SYNA · 100% match
  2. Khurram JamilChief Medical Officer · GALT · 100% match
  3. Marie MendozaGeneral Counsel · KTOS · 100% match
  4. Jason AdairChief Business Officer · LQDA · 100% match
  5. Chad M. SmithCOO · BETR · 100% match

Matched on seven traits of each insider's trading pattern (buy share, pace, typical size, planned sales, seasonality, buying after drops, number of companies). Pattern matching on public filings; history, not a prediction.

Reported trades

Filed Stock Type Shares Price Value Since
Nov 10SEC EWEdwards Lifesciences Corp Sell Plan 61940,034 held (−2%) $104.25 $65K -0.5%
Oct 8SEC EWEdwards Lifesciences Corp Sell Plan 61940,034 held (−2%) $85.65 $53K +21.1%
Sep 11SEC EWEdwards Lifesciences Corp Sell Plan 61940,034 held (−2%) $87.51 $54K +18.5%
Aug 11SEC EWEdwards Lifesciences Corp Sell Plan 61940,034 held (−2%) $92.03 $57K +12.7%
Jul 10SEC EWEdwards Lifesciences Corp Sell Plan 61940,034 held (−2%) $91.70 $57K +13.1%
Jun 30SEC EWEdwards Lifesciences Corp Sell Plan 61940,411 held (−2%) $91.40 $57K +13.5%
May 18SEC EWEdwards Lifesciences Corp Sell Plan 62040,411 held (−2%) $81.14 $50K +27.8%
May 4SEC EWEdwards Lifesciences Corp Sell Plan 1934,934 held (−0%) $83.99 $2K +23.5%
May 4SEC EWEdwards Lifesciences Corp Sell Plan 1,00033,934 held (−3%) $82.99 $83K +25.0%
May 4SEC EWEdwards Lifesciences Corp Sell Plan 1,01933,682 held (−3%) $83.98 $86K +23.5%
Apr 6SEC EWEdwards Lifesciences Corp Sell Plan 1,01933,934 held (−3%) $80.98 $83K +28.1%
Mar 11SEC EWEdwards Lifesciences Corp Sell Plan 1,01933,934 held (−3%) $85.38 $87K +21.5%
Jan 9SEC EWEdwards Lifesciences Corp Sell Plan 1,01922,002 held (−4%) $85.70 $87K +21.0%
Dec 12SEC EWEdwards Lifesciences Corp Sell Plan 1,01922,002 held (−4%) $84.03 $86K +23.4%
Nov 10SEC EWEdwards Lifesciences Corp Sell Plan 1,02022,002 held (−4%) $82.55 $84K +25.7%
  • Sell

    Cvp, Tavr Daniel J. Lippis sold $65K of EW at $104.25 — pre-scheduled 10b5-1 plan sale.

  • Sell

    Cvp, Tavr Daniel J. Lippis sold $53K of EW at $85.65 — pre-scheduled 10b5-1 plan sale.

  • Sell

    Cvp, Tavr Daniel J. Lippis sold $54K of EW at $87.51 — pre-scheduled 10b5-1 plan sale.

  • Sell

    Cvp, Tavr Daniel J. Lippis sold $57K of EW at $92.03 — pre-scheduled 10b5-1 plan sale.

  • Sell

    Cvp, Tavr Daniel J. Lippis sold $57K of EW at $91.70 — pre-scheduled 10b5-1 plan sale.

  • Sell

    Cvp, Tavr Daniel J. Lippis sold $57K of EW at $91.40 — pre-scheduled 10b5-1 plan sale.

Follow Daniel J. Lippis

Get one email when Daniel J. Lippis files a new purchase or sale. Free.

At most one email a day about Daniel J. Lippis, plus the free Monday email. Already subscribed? Use the same email to add them. Unsubscribe anytime. Facts from public filings, not advice.